Chemical Compound

Letermovir

CAS Registry Number 917389-32-3
Letermovir chemical structure
Primary Record

Letermovir

In stock
3,752 g
Purity
98.8 %
CAS
917389-32-3

Compound Identifiers & Properties

CAS
917389-32-3
PubChem CID
45138674
SMILES
COC1=C(C=C(C=C1)C(F)(F)F)N2[C@H](C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O
Canonical SMILES
COc1cccc(N2CCN(C3=Nc4c(F)cccc4[C@H](CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1

Names & Synonyms

  • Letermovir
  • Prevymis
  • 917389-32-3
  • letermovirum
  • AIC246
  • Letermovir [INN]
  • Prevymis (TN)
  • AIC-246
  • Letermovir (Standard)
  • Letermovir [USAN:INN]
  • Letermovir(AIC246)
  • AIC 246
  • LETERMOVIR [MI]
  • RefChem:57199
  • LETERMOVIR [JAN]
  • 1H09Y5WO1F
  • LETERMOVIR [USAN]
  • UNII-1H09Y5WO1F
  • Letermovir(AIC-246)?
  • MK-8228
  • D0G8PA
  • LETERMOVIR [WHO-DD]
  • MFCD22572725
  • Letermovir (JAN/USAN/INN)
  • SCHEMBL379403
  • DTXSID40238683
  • FWYSMLBETOMXAG-QHCPKHFHSA-N
  • orb1301825
  • CHEMBL1241951
  • LETERMOVIR [ORANGE BOOK]
  • SCHEMBL29367234
  • SCHEMBL29438348
  • DTXCID90161174
  • J05AX18
  • C29H28F4N4O4
  • EX-A1871
  • BDBM50614677
  • EBC-27337
  • HY-15233R
  • s8873
  • AKOS030526995
  • ZINC100369359
  • CS-1571
  • DB12070
  • MK-8828
  • AIC246;AIC 246;AIC-246
  • NCGC00378936-01
  • NCGC00378936-02
  • AC-35698
  • AS-56206
  • DA-74962
  • FL104029
  • HY-15233
  • SY247494
  • (S)-2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetic acid
  • A3550
  • NS00073296
  • J3.556.145E
  • D10801
  • D71052
  • A902281
  • EN300-18167086
  • 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acid
  • BRD-K94288301-001-01-7
  • Q15409407
  • 2-((4S)-8-Fluoro-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3-(2-methoxy-5-(trifluoromethyl)phenyl)-4H-quinazolin-4-yl)acetic acid
  • 4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-(4-(3-methoxyphenyl)-1-piperazinyl)-3-(2-methoxy-5-(trifluoromethyl)phenyl)-, (4S)-
  • B2693-460490
  • 2-[(4S)-8-fluoro-3-[2-methoxy-5-(trifluoromethyl)phenyl]-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3,4-dihydroquinazolin-4-yl]acetic acid
  • (4S)-2-(8-FLUORO-2-(4-(3-METHOXYPHENYL)PIPERAZIN-1-YL)-3-(2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL)-3,4-DIHYDROQUINAZOLIN-4-YL)ACETIC ACID
  • (4S)-2-{8-Fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4-yl}acetic acid
  • (4S)-8-Fluoro-2-[4-(3-methoxyphenyl)piperazino]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazoline-4-acetic acid
  • (S)-[8-fluoro-2-[4-(3-methoxyphenyl)piperazine-1-yl]-3-(2-methoxy-5-trifluoromethylphenyl)-3,4-dihydroquinazoline-4-yl]acetic acid
  • (S)-{8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-(2-methoxy-5-trifluoromethylphenyl)-3,4-dihydro-quinazolin-4-yl}acetic acid
  • (S)-{8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-(2-methoxy-5-trifluoromethylphenyl)-3,4-dihydroquinazolin-4-yl}acetic acid
  • (S)-{8-fluoro-2-[4-(3-methoxyphenyl)piperazine-1-yl]-3-(2-methoxy-5-trifluoromethylphenyl)-3,4-dihydroquinazoline-4-yl}acetic acid
  • {(4S)-8-Fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4-yl}acetic acid
  • 805-689-9
  • Letermovir;4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, (4S)-; (4S)-8-Fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4-quinazolineacetic acid; AIC 246; Letermovir; Prevymis
  • methyl(S)-2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetate
  • Prevymis; AIC 246; (S)-2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetic acid